Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma
Authors
Keywords
-
Journal
NATURE NEUROSCIENCE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-19
DOI
10.1038/s41593-020-0628-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma
- (2019) Hiromichi Suzuki et al. NATURE
- Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA
- (2018) K. G. Paulson et al. Nature Communications
- ConTra v3: a tool to identify transcription factor binding sites across species, update 2017
- (2017) Łukasz Kreft et al. NUCLEIC ACIDS RESEARCH
- Resistance to checkpoint blockade therapy through inactivation of antigen presentation
- (2017) Moshe Sade-Feldman et al. Nature Communications
- HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC- Driven Medulloblastoma
- (2016) Yanxin Pei et al. CANCER CELL
- Genomic Approaches to Understanding Response and Resistance to Immunotherapy
- (2016) D. A. Braun et al. CLINICAL CANCER RESEARCH
- Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion
- (2016) Martin Chopra et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Divergent clonal selection dominates medulloblastoma at recurrence
- (2016) A. Sorana Morrissy et al. NATURE
- The Journey from Discoveries in Fundamental Immunology to Cancer Immunotherapy
- (2015) Jacques F.A.P. Miller et al. CANCER CELL
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Combined MYC and P53 Defects Emerge at Medulloblastoma Relapse and Define Rapidly Progressive, Therapeutically Targetable Disease
- (2015) Rebecca M. Hill et al. CANCER CELL
- Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia
- (2015) Xi Wang et al. CELLULAR SIGNALLING
- Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097
- (2015) E. Weisberg et al. MOLECULAR CANCER THERAPEUTICS
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- Peripheral Administration of Tumor Necrosis Factor-Alpha Induces Neuroinflammation and Sickness but Not Depressive-Like Behavior in Mice
- (2015) Steven Biesmans et al. Biomed Research International
- Antitumor cytotoxicity induced by bone-marrow-derived antigen-presenting cells is facilitated by the tumor suppressor protein p53 via regulation of IL-12
- (2015) Tania L. Slatter et al. OncoImmunology
- Systemic use of tumor necrosis factor alpha as an anticancer agent
- (2015) Nicholas J. Roberts et al. Oncotarget
- Human pontine glioma cells can induce murine tumors
- (2014) Viola Caretti et al. ACTA NEUROPATHOLOGICA
- Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma
- (2014) Paul A. Northcott et al. NATURE
- Pax3 expression enhances PDGF-B-induced brainstem gliomagenesis and characterizes a subset of brainstem glioma
- (2014) Katherine L. Misuraca et al. Acta Neuropathologica Communications
- MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells
- (2013) P. Leone et al. JNCI-Journal of the National Cancer Institute
- Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma
- (2013) P. W. Lewis et al. SCIENCE
- p53 increases MHC class I expression by upregulating the endoplasmic reticulum aminopeptidase ERAP1
- (2013) Bei Wang et al. Nature Communications
- An Animal Model of MYC-Driven Medulloblastoma
- (2012) Yanxin Pei et al. CANCER CELL
- Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment
- (2012) Rintaro Hashizume et al. JOURNAL OF NEURO-ONCOLOGY
- HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment
- (2012) Till Milde et al. JOURNAL OF NEURO-ONCOLOGY
- p53 activation of mesenchymal stromal cells partially abrogates microenvironment-mediated resistance to FLT3 inhibition in AML through HIF-1 -mediated down-regulation of CXCL12
- (2011) K. Kojima et al. BLOOD
- Medulloblasoma: challenges for effective immunotherapy
- (2011) Adam M. Sonabend et al. JOURNAL OF NEURO-ONCOLOGY
- Universal Poor Survival in Children With Medulloblastoma Harboring SomaticTP53Mutations
- (2010) Uri Tabori et al. JOURNAL OF CLINICAL ONCOLOGY
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic polymorphisms among C57BL/6 mouse inbred strains
- (2010) Esther Zurita et al. TRANSGENIC RESEARCH
- Suppression of induced pluripotent stem cell generation by the p53–p21 pathway
- (2009) Hyenjong Hong et al. NATURE
- The Nuclear Factor NF- B Pathway in Inflammation
- (2009) T. Lawrence Cold Spring Harbor Perspectives in Biology
- Medulloblastoma Can Be Initiated by Deletion of Patched in Lineage-Restricted Progenitors or Stem Cells
- (2008) Zeng-Jie Yang et al. CANCER CELL
- Dose translation from animal to human studies revisited
- (2007) Shannon Reagan-Shaw et al. FASEB JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now